British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017

Br J Dermatol. 2017 Nov;177(5):1170-1201. doi: 10.1111/bjd.15930.
No abstract available

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Administration, Oral
  • Adrenal Cortex Hormones / administration & dosage
  • Aftercare
  • Blister / therapy
  • Chemotherapy, Adjuvant
  • Child
  • Clinical Laboratory Techniques / methods
  • Dermatologic Agents / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Female
  • Forecasting
  • Humans
  • Immunosorbent Techniques
  • Immunosuppressive Agents / therapeutic use
  • Infusions, Intravenous
  • Nursing Care
  • Pemphigus / diagnosis
  • Pemphigus / therapy*
  • Photopheresis / methods
  • Plasma Exchange / methods
  • Plasmapheresis / methods
  • Pregnancy
  • Pregnancy Complications / therapy
  • Refusal to Treat
  • Remission Induction
  • Social Support

Substances

  • Adrenal Cortex Hormones
  • Dermatologic Agents
  • Immunosuppressive Agents